TOI (The Oncology Institute, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by TOI officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-29 | MARK STOLPER | Director | A | — | — |
| 2026-07-29 | Brad Hively | Director | A | — | — |
| 2026-07-29 | Mohit Kaushal | Director | A | — | — |
| 2026-07-29 | KIMBERLY JO TZOUMAKAS | Director | A | — | — |
| 2026-07-29 | Mark L Pacala | Director | A | — | — |
| 2026-07-29 | Anne McGeorge | Director | A | — | — |
| 2026-07-29 | Karen Marie Johnson | Director | A | — | — |
| 2026-07-22 | Jorey Chernett | 10%+ Owner | Buy | — | — |
| 2026-07-16 | Yale Podnos | Chief Medical Officer | MIXED | — | — |
| 2026-07-13 | Jorey Chernett | 10%+ Owner | Buy | — | — |
| 2026-07-09 | MARK STOLPER | Director | A | — | — |
| 2026-07-09 | KIMBERLY JO TZOUMAKAS | Director | A | — | — |
| 2026-06-24 | Jorey Chernett | 10%+ Owner | Buy | — | — |
| 2022-08-23 | TOI HC I, LLC | 10%+ Owner | Sell | — | — |
| 2022-08-16 | Havencrest Healthcare Partners GP, LLC | 10%+ Owner | Sell | — | — |
| 2022-06-14 | Jimmy Holdings, Inc. | 10%+ Owner | Sell | — | — |
| 2022-05-19 | Mihir Shah | Chief Financial Officer | A | — | — |
| 2022-05-13 | Jimmy Holdings, Inc. | 10%+ Owner | Sell | — | — |
| 2022-03-29 | Scott Dalgleish | Chief Financial Officer | A | — | — |
| 2022-03-29 | Daniel Virnich | President | A | — | — |
| 2022-03-29 | Brad Hively | Chief Executive Officer | A | — | — |
| 2022-03-29 | Matthew P Miller | Chief Operating Officer | A | — | — |
| 2022-03-29 | Yale Podnos | Chief Medical Officer | A | — | — |
| 2022-03-23 | RICHARD A BARASCH | Director | A | — | — |
| 2022-03-23 | Scott Dalgleish | Chief Financial Officer | A | — | — |
| 2022-03-23 | Karen Marie Johnson | Director | A | — | — |
| 2022-03-23 | Mohit Kaushal | Director | A | — | — |
| 2022-03-23 | Brad Hively | Chief Executive Officer | A | — | — |
| 2022-03-23 | Daniel Virnich | President | A | — | — |
| 2022-03-23 | RAVI YANG SARIN | Director | A | — | — |
| 2022-03-23 | Anne McGeorge | Director | A | — | — |
| 2022-03-23 | Matthew P Miller | Chief Operating Officer | A | — | — |
| 2022-03-23 | Yale Podnos | Chief Medical Officer | A | — | — |
| 2022-03-23 | Maeve O'Meara | Director | A | — | — |
| 2021-11-24 | RICHARD A BARASCH | Director | Buy | — | — |
| 2021-11-24 | RICHARD A BARASCH | Director | Buy | — | — |
| 2021-11-22 | RAVI YANG SARIN | Director | A | — | — |
| 2021-11-18 | Mohit Kaushal | Director | M | — | — |
| 2021-11-18 | RICHARD A BARASCH | Director | Buy | — | — |
| 2021-11-18 | RICHARD A BARASCH | Director | MIXED | — | — |
| 2021-11-18 | Brad Hively | Chief Executive Officer | A | — | — |
| 2021-11-16 | RICHARD A BARASCH | Director | MIXED | — | — |
| 2021-11-16 | Daniel Virnich | Chief Operating Officer | A | — | — |
| 2021-11-16 | Brad Hively | Chief Executive Officer | A | — | — |
| 2021-11-16 | Scott Dalgleish | Chief Financial Officer | A | — | — |
| 2021-11-16 | Yale Podnos | Chief Medical Officer | A | — | — |
| 2021-11-16 | RAVI YANG SARIN | Director | A | — | — |
| 2021-11-16 | Mohit Kaushal | Director | MIXED | — | — |
| 2021-11-16 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10%+ Owner | C | — | — |
| 2021-11-16 | STEVEN HOCHBERG | 10%+ Owner | C | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 15,621,231 | — |
| — | 10%+ Owner | 15,518,321 | — |
| — | 10%+ Owner | 10,648,858 | — |
| — | 10%+ Owner | 6,295,688 | — |
| — | Director | 4,125,765 | — |
| — | 10%+ Owner | 1,605,477 | — |
| — | Chief Executive Officer | 710,829 | — |
| — | Director | 332,535 | — |
| — | Director | 319,410 | — |
| — | Director | 286,881 | — |
| — | Chief Medical Officer | 259,527 | — |
| — | President | 237,251 | — |
| — | Director | 205,716 | — |
| — | Chief Financial Officer | 151,008 | — |
| — | Director | 142,018 | — |
| — | Chief Operating Officer | 78,611 | — |
| — | Director | 56,957 | — |
| — | Director | 46,301 | — |
| — | Chief Financial Officer | 32,121 | — |
| — | Director | 19,992 | — |
| — | 10%+ Owner | 40 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the TOI quote page; the site-wide leaderboard is on the insider transactions hub.